Onward, Ho!

imageAs many of you know, Katelin and I are on the road trip of our lives as we relocate from Massachusetts to California, stopping many times to FINALLY meet some of the many families around America. Now, we are in Texas on the final leg of our half way mark. What an opportunity we have had so far. We have been very honored to have been welcomed into so many homes by gracious and accommodating people.

However, as we go along, spreading awareness, handing out purple cards, it has seemed a bit like time has stood still for us! A month gone and it seems like we just packed up yesterday…ok the day before yesterday ;). But time has NOT stood still in research and yesterday Neuren released the announcement that the Fragile X study with Trofinetide (NNZ-2566) is complete! and TBI close behind.

Such good news. I hope sometimes, that if the FDA does not approve Trofinetide for Rett syndrome first, that an approval for either of these two others can mean off label use for Rett Syndrome. A back door in.

The road through Texas has been monotonous for long time, so it has been a long time without any updates on Trofinetide. Now, today, not so. We’re moving on to New Mexico and Trofinetide is moving on, too, one more step closer to both our destinations.

see below for the update. šŸ™‚

http://www.neurenpharma.com/IRM/ShowDownloadDoc.aspx?SiteId=386&AnnounceGuid=c367cc86-5d6e-4dac-ba0d-d66731d6e668

Advertisements
This entry was posted in Neuren, Neuren Pharmaceuticals, Rett Syndrome, Trail to a Texas Trial, Trofinetide. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s